跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 369 条关于
“APOE E4”
全部
369
临床试验
235
药物
37
机构
1
资讯
96
去年
CHMP Recommends Approval of Lecanemab for Early Alzheimer's Disease in the EU
2年前
Alector Presents Baseline Data from INVOKE-2 Phase 2 Trial of AL002 for Early Alzheimer's Disease
去年
APOE Genotype Disclosure in Alzheimer's Trials Under Scrutiny Amidst Safety Concerns
去年
Roche and Lilly's Alzheimer's Blood Test Receives FDA Breakthrough Device Designation
5个月前
Comprehensive Review Confirms Alzheimer's Amyloid-Targeting Antibodies Show Minimal Clinical Benefit Despite Plaque Clearance
去年
Novel CSF Biomarkers CHIT1 and DDAH1 May Predict ARIA Risk in Alzheimer's Patients Receiving Anti-Amyloid Therapies
去年
U.S. POINTER Study Demonstrates Structured Lifestyle Interventions Significantly Improve Cognitive Function in At-Risk Older Adults
去年
Revvity's EUROIMMUN Launches APOE Genotyping Assay for Alzheimer's Therapy Risk Assessment
上个月
APOE-Stratified GWAS Uncovers New Alzheimer's Risk Loci and Supports A Priori APOE Stratification in AD Trials
上个月
Niki BioSolutions Enters Strategic Agreement to Provide APOE Genotyping Services for Progressive Medical Research
第 1 页,共 10 页
上一页
下一页